Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 23, 2020 - Issue 7
704
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Omega-3 fatty acids and anxiety: A systematic review of the possible mechanisms at play

ORCID Icon, , ORCID Icon & ORCID Icon

References

  • Beck AT, Clark DA. An information processing model of anxiety: automatic and strategic processes. Behav Res Ther 1997;35(1):49–58.
  • Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 2012;53(8):573–86.
  • Hendriks SM, Spijker J, Licht CM, Beekman AT, Hardeveld F, de Graaf R, et al. Disability in anxiety disorders. J Affect Disord 2014;166:227–33.
  • Merikangas KR, Swanson SA. Comorbidity in Anxiety Disorders. In: Stein M, Steckler T, editors. Behavioral Neurobiology of Anxiety and Its Treatment. Current Topics in Behavioral Neurosciences. Heidelberg: Springer, Berlin; 2009. p. 37–59.
  • Otto MW, Smits JA, Reese HE. Cognitive-behavioral therapy for the treatment of anxiety disorders. J Clin Psychiatry 2004;65(5):34–41.
  • Taylor S, Abramowitz JS, McKay D. Non-adherence and non-response in the treatment of anxiety disorders. J Anxiety Disord 2012;26(5):583–9.
  • Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry 2016;3(5):415–24.
  • Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005;19(6):567–96.
  • Deacon BJ, Farrell NR, Kemp JJ, Dixon LJ, Sy JT, Zhang AR, McGrath PB. Assessing therapist reservations about exposure therapy for anxiety disorders: The therapist beliefs about exposure scale. J Anxiety Disord 2013;27(8):772–80.
  • Walsh R. Lifestyle and mental health. American Psychologist 2011;66(7):579–92.
  • Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008;9(7):568–78.
  • Kaplan BJ, Rucklidge JJ, Romijn a, McLeod K. The emerging field of nutritional mental health: inflammation, the microbiome, oxidative stress, and mitochondrial function. Clin Psychol Sci 2015;3(6):964–80.
  • Perica MM, Delaš I. Essential fatty acids and psychiatric disorders. Nutr Clin Pract 2011;26(4):409–25.
  • Lewis MD. Concussions, traumatic brain injury, and the innovative use of omega-3s. J Am Coll Nutr 2016;35(5):469–75.
  • Anderson BM, Ma DWL. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis 2009;8(1):33.
  • Burdge GC, Calder PC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development 2005;45(5):581–97.
  • Jacka FN, Pasco JA, Williams LJ, Meyer BJ, Digger R, Berk M. Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women. Br J Nutr 2013;109(11):2059–66.
  • Verly-Miguel MVB, Farias DR, Pinto TDJP, Lepsch J, Nardi AE, Kac G. Serum docosahexaenoic acid (DHA) is inversely associated with anxiety disorders in early pregnancy. J Anxiety Disord 2015;30:34–40.
  • dos Santos Vaz J, Kac G, Emmett P, Davis JM, Golding J, Hibbeln JR. Dietary patterns, n-3 fatty acids intake from seafood and high levels of anxiety symptoms during pregnancy: findings from the Avon longitudinal study of parents and children. PLoS ONE 2013;8(7):1–9.
  • Green P, Hermesh H, Monselise A, Marom S, Presburger G, Weizman A. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 2006;16(2):107–13.
  • Buydens-Branchey L, Branchey M. N-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 2006;26(6):661–5.
  • Chen HF, Su HM. Fish oil supplementation of maternal rats on an n-3 fatty acid-deficient diet prevents depletion of maternal brain regional docosahexaenoic acid levels and has a postpartum anxiolytic effect. J Nutr Biochem 2012;23(3):299–305.
  • Sohrabi N, Kashanian M, Ghafoori SS, Malakouti SK. Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: “a pilot trial”. Complement Ther Med 2013;21(3):141–6.
  • Khandaker GM, Zammit S, Lewis G, Jones PB. Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: findings from the ALSPAC cohort. Neurobiol Stress 2016;4:55–61.
  • Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis 2006;185(2):320–6.
  • Zhang J-M, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin 2009;69(2):482–9.
  • Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63(1):116–22.
  • Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 2012;26(6):988–95.
  • Li K, Huang T, Zheng J, Wu K, Li D. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS ONE 2014;9(2):1–28.
  • Su KP. Biological mechanism of antidepressant effect of omega–3 fatty acids: how does fish oil act as a ‘mind-body interface’? Neurosignals 2009;17(2):144–52.
  • Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000;10(3):381–91.
  • Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron 2002;36(4):555–8.
  • Wu D. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2005;2(1):120–8.
  • Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013;14(1):7–23.
  • Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59(12):1116–27.
  • Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455(7215):894–902.
  • Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27(10):589–94.
  • Jacobsen JPR, Medvedev IO, Caron MG. The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse. Philos Trans R Soc, B 2012;367(1601):2444–59.
  • Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15(12):7929–39.
  • Pudell C, Vicente BA, Delattre AM, Carabelli B, Mori MA, Suchecki D, et al. Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised rats. Eur J Neurosci 2014;39(2):266–74.
  • Levant B, Ozias MK, Davis PF, Winter M, Russell KL, Carlson SE, et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008;33(9):1279–92.
  • Rao JS, Ertley RN, Lee HJ, DeMar Jr JC, Arnold JT, Rapoport SI, Bazinet RP. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007;12(1):36–46.
  • Vines A, Delattre AM, Lima MMS, Rodrigues LS, Suchecki D, MacHado RB, et al. The role of 5-HT 1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 2012;62(1):184–91. doi:10.1016/j.neuropharm.2011.06.017.
  • Wu A, Ying ZHE, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004;21(10):1457–67. doi:10.1089/neu.2004.21.1457.
  • Ferreira CF, Bernardi JR, Bosa VL, Schuch I, Goldani MZ, Kapczinski F, et al. Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids Health Dis 2014;13:44.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151(4):264–9.
  • Higgins JPT, Green S., editors. 2011. Cochrane handbook for systematic reviews of interventions (Version 5.1.0), The Cochrane Collaboration. Retrieved from http://www.cochrane-handbook.org
  • Ryan R. 2013. Cochrane Consumers and Communication Review Group. ‘Cochrane Consumers and Communication Review Group: data synthesis and analysis’. http://cccrg.cochrane.org
  • Giles GE, Mahoney CR, Urry HL, Brunyé TT, Taylor HA, Kanarek RB. Omega-3 fatty acids and stress-induced changes to mood and cognition in healthy individuals. Pharmacol Biochem Behav 2015;132:10–9.
  • Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 2011;25(8):1725–34.
  • Matsumura K, Noguchi H, Nishi D, Matsuoka Y. The effect of omega-3 fatty acids on psychophysiological assessment for the secondary prevention of posttraumatic stress disorder: an open-label pilot study. Glob J Health Sci 2012;4(1):3.
  • Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hamazaki T, Hashimoto K. Potential role of brain-derived neurotrophic factor in omega–3 fatty acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study. Psychother Psychosom 2011;80(5):310–2.
  • Matsuoka Y, Nishi D, Hamazaki K, Yonemoto N, Matsumura K, Noguchi H, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial. J Clin Psychiatry 2015;76(8):e1015–22.
  • Yehuda S, Rabinovitz S, Mostofsky DI. Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci 2005;8(4):265–7.
  • Abelson JL, Khan S, Liberzon I, Young EA. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007;24(1):66–76.
  • Barbadoro P, Annino I, Ponzio E, Romanelli RM, D’errico MM, Prospero E, Minelli A. Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics. Mol Nutr Food Res 2013;57(6):1110–14.
  • Delarue JOCP, Matzinger O, Binnert C, Schneiter P, Chiolero R, Tappy L. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 2003;29(3):289–95.
  • Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Front Psychiatry 2014;5:593.
  • Batelaan NM, Seldenrijk A, Bot M, Van Balkom AJ, Penninx BW. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. Br J Psychiatry 2016;208(3):223–31.
  • Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010;56(1):38–46.
  • Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS. Dietary fish and ω-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008;117(9):1130–7.
  • Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr 2012;107(S2):S195–200.
  • Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106(21):2747–57.
  • Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010;68(5):280–9.
  • Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011;72(12):1577–84.
  • Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Martínez JA, Moreno-Aliaga MJ. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 2013;69(3):633–51.
  • Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci 2015;7:52.
  • Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007;99(6):S35–43.
  • Xin W, Wei W, Li X. Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2012;12(1):77.
  • Okereke OI, Rosner BA, Kim DH, Kang JH, Cook NR, Manson JE, et al. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol 2012;72(1):124–34.
  • Kyrozis A, Psaltopoulou T, Stathopoulos P, Trichopoulos D, Vassilopoulos D, Trichopoulou A. Dietary lipids and geriatric depression scale score among elders: the EPIC-Greece cohort. J Psychiatr Res 2009;43(8):763–9.
  • Howe P, Meyer B, Record S, Baghurst K. Dietary intake of long-chain ω-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 2006;22(1):47–53.
  • Freedman LS, Commins JM, Moler JE, Arab L, Baer DJ, Kipnis V, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol 2014;180(2):172–88.
  • Johnston DT, Deuster Pa, Harris WS, Macrae H, Dretsch MN. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. servicemembers. Nutr Neurosci 2013;16(1):30–8.
  • Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014;72(1):48–54.
  • Yurko-Mauro K, Alexander DD, Van Elswyk ME. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PLoS One 2015;10(3):e0120391.
  • Chouinard-Watkins R, Lacombe RS, Bazinet RP. Mechanisms regulating brain docosahexaenoic acid uptake: what is the recent evidence? Curr Opin Clin Nutr Metab Care 2018;21(2):71–7.
  • Ochiai Y, Uchida Y, Ohtsuki S, Tachikawa M, Aizawa S, Terasaki T. The blood-brain barrier fatty acid transport protein 1 (FATP 1/SLC 27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport. J Neurochem 2017;141(3):400–12.
  • Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014;509(7501):503–6.
  • Sugasini D, Thomas R, Yalagala PC, Tai LM, Subbaiah PV. Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. Sci Rep 2017;7(1):11263.
  • Zibaeenezhad MJ, Ghavipisheh M, Attar A, Aslani A. Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial. Nutr Diabetes 2017;7(12):e54.
  • Cederholm T, Salem Jr N, Palmblad J. ω-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr 2013;4(6):672–6.
  • Konagai C, Yanagimoto K, Hayamizu K, Han L, Tsuji T, Koga Y. Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers. Clin Interv Aging 2013;8:1247.
  • Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91(3):757–70.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
  • Hyland P, Shevlin M, McNally S, Murphy J, Hansen M, Elklit A. Exploring differences between the ICD-11 and DSM-5 models of PTSD: does it matter which model is used? J Anxiety Disord 2016;37:48–53.
  • Peterson A, Thome J, Frewen P, Lanius RA. Resting-state neuroimaging studies: a new way of identifying differences and similarities among the anxiety disorders? Can J Psychiatry 2014;59(6):294–300.
  • Antypa N, Van der Does aJW, Smelt aHM, Rogers RD. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol 2009;23(7):831–40.
  • Lespérance F, Frasure-Smith N, St-Andre E, Turecki G, Lesperance P, Wisniewski SR. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry 2011;72(8):1054–62.
  • Hayes AF, Preacher KJ. Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol 2014;67(3):451–70.
  • Bakewell L, Burdge GC, Calder PC. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 2006;96(1):93–9.
  • Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 2008;99(1):168–74.
  • Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis AM, Garneau V, et al. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J Nutrigenet Nutrigenomics 2013;6(2):73–82.
  • Iso H, Sato S, Folsom AR, Shimamoto T, Terao A, Munger RG, et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol 1989;18(2):374–81.
  • Food and Agriculture Organization of the United Nations. 2008. Fats and fatty acids in human nutrition, Report of an expert consultation. FAO, Food and Nutrition Paper, 91.
  • Al-Numair K, Lewis NM, Evans S. Omega-3 fatty acid consumption and food sources differ among elderly men living in coastal and internal regions of Saudi Arabia. Pakistan J Nutr 2005;4(2):106–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.